{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:24:18Z","timestamp":1791361458878,"version":"4.3.1"},"reference-count":92,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T00:00:00Z","timestamp":1264636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Olesoxime (TRO19622) is a novel mitochondrial-targeted neuroprotective compound undergoing a pivotal clinical efficacy study in Amyotrophic Lateral Sclerosis (ALS) and also in development for Spinal Muscular Atrophy (SMA). It belongs to a new family of cholesterol-oximes identified for its survival-promoting activity on purified motor neurons deprived of neurotrophic factors. Olesoxime targets proteins of the outer mitochondrial membrane, concentrates at the mitochondria and prevents permeability transition pore opening mediated by, among other things, oxidative stress. Olesoxime has been shown to exert a potent neuroprotective effect in various in vitro and in vivo models. In particular olesoxime provided significant protection in experimental animal models of motor neuron disorders and more particularly ALS. Olesoxime is orally active, crosses the blood brain barrier, and is well tolerated. Collectively, its pharmacological properties designate olesoxime as a promising drug candidate for motor neuron diseases.<\/jats:p>","DOI":"10.3390\/ph3020345","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T13:03:45Z","timestamp":1264683825000},"page":"345-368","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound"],"prefix":"10.3390","volume":"3","author":[{"given":"Thierry","family":"Bordet","sequence":"first","affiliation":[{"name":"Trophos, Parc Scientifique de Luminy, Case 931, 13288 Marseille cedex 9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Berna","sequence":"additional","affiliation":[{"name":"Trophos, Parc Scientifique de Luminy, Case 931, 13288 Marseille cedex 9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Abitbol","sequence":"additional","affiliation":[{"name":"Trophos, Parc Scientifique de Luminy, Case 931, 13288 Marseille cedex 9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Pruss","sequence":"additional","affiliation":[{"name":"Trophos, Parc Scientifique de Luminy, Case 931, 13288 Marseille cedex 9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2010,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mitsumoto, H., Przedborski, S., and Gordon, P.H. (2006). Amyotrophic Lateral Sclerosis, Taylor & Francis Group.","DOI":"10.1201\/b14133"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","article-title":"Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis","volume":"322","author":"Bordet","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cohen, J., and Wilkin, G. (1995). Nerve Cell Culture: A practical approach, Oxford UP.","DOI":"10.1093\/oso\/9780199634859.001.0001"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0896-6273(95)90287-2","article-title":"Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death","volume":"14","author":"Greenlund","year":"1995","journal-title":"Neuron"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1523\/JNEUROSCI.18-03-00923.1998","article-title":"Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation","volume":"18","author":"Estevez","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrn2631","article-title":"Microtubule assembly, organization and dynamics in axons and dendrites","volume":"10","author":"Conde","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/345440a0","article-title":"Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy","volume":"345","author":"Sendtner","year":"1990","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/exnr.1996.0044","article-title":"Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons: Time course analysis and relation to NADPH-diaphorase activity","volume":"138","author":"Rossiter","year":"1996","journal-title":"Exp. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1046\/j.1460-9568.2000.00241.x","article-title":"Caspase-3 is activated following axotomy of neonatal facial motoneurons and caspase-3 gene deletion delays axotomy-induced cell death in rodents","volume":"12","author":"Vanderluit","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1018508819191","article-title":"Diphenylpiperazines enhance regeneration after facial nerve injury","volume":"26","author":"Tong","year":"1997","journal-title":"J. Neurocytol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.cdd.4401258","article-title":"In vivo application of mitochondrial pore inhibitors blocks the induction of apoptosis in axotomized neonatal facial motoneurons","volume":"10","author":"Vanderluit","year":"2003","journal-title":"Cell Death Differ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-510X(86)90109-7","article-title":"Methods for producing a reproducible crush in the sciatic and tibial nerve of the rat and rapid and precise testing of return of sensory function. Beneficial effects of melanocortins","volume":"74","author":"Brakkee","year":"1986","journal-title":"J. Neurol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: Insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/bies.20283","article-title":"Is spinal muscular atrophy the result of defects in motor neuron processes?","volume":"27","author":"Briese","year":"2005","journal-title":"Bioessays"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: Why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/hmg\/10.18.1925","article-title":"Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice","volume":"10","author":"Bordet","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","article-title":"Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy","volume":"12","author":"Lesbordes","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/hmg\/9.5.803","article-title":"Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2","volume":"9","author":"Azzouz","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/40299","article-title":"Inhibition of ICE slows ALS in mice","volume":"388","author":"Friedlander","year":"1997","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.288.5464.335","article-title":"Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model","volume":"288","author":"Li","year":"2000","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy","volume":"15","author":"Pearn","year":"1978","journal-title":"J. Med. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.ejhg.5200667","article-title":"Best practice guidelines for molecular analysis in spinal muscular atrophy","volume":"9","author":"Scheffer","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1195-335","article-title":"A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients","volume":"11","author":"Bussaglia","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1542\/peds.2008-2952K","article-title":"Special considerations in the respiratory management of spinal muscular atrophy","volume":"123","author":"Schroth","year":"2009","journal-title":"Pediatrics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/geno.1996.4551","article-title":"cDNA isolation, expression, and chromosomal localization of the mouse survival motor neuron gene (Smn)","volume":"40","author":"Viollet","year":"1997","journal-title":"Genomics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1101\/gr.7.4.339","article-title":"Cloning, characterization, and copy number of the murine survival motor neuron gene: Homolog of the spinal muscular atrophy-determining gene","volume":"7","author":"DiDonato","year":"1997","journal-title":"Genome Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"The inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos","volume":"94","author":"Schrank","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Chang","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/hmg\/9.5.849","article-title":"Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy","volume":"9","author":"Frugier","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Nicole","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(00)02910-3","article-title":"Description of a short-term Taxol-induced nociceptive neuropathy in rats","volume":"887","author":"Authier","year":"2000","journal-title":"Brain Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0161-813X(03)00043-3","article-title":"A new animal model of vincristine-induced nociceptive peripheral neuropathy","volume":"24","author":"Authier","year":"2003","journal-title":"Neurotoxicology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1097-0142(19820301)49:5<859::AID-CNCR2820490506>3.0.CO;2-9","article-title":"Possible enhancement of vincristine neuropathy by VP-16","volume":"49","author":"Thant","year":"1982","journal-title":"Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","article-title":"A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel","volume":"94","author":"Polomano","year":"2001","journal-title":"Pain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2006.01.037","article-title":"Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction","volume":"122","author":"Flatters","year":"2006","journal-title":"Pain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2005.12.013","article-title":"Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy","volume":"397","author":"Flatters","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1213\/01.ane.0000204318.35194.ed","article-title":"Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy","volume":"102","author":"Siau","year":"2006","journal-title":"Anesth. Analg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pain.2007.06.001","article-title":"Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitineitine","volume":"135","author":"Xiao","year":"2008","journal-title":"Pain"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2009.09.006","article-title":"Olesoxime (cholest-4-en-3-one, oxime): Analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel","volume":"147","author":"Xiao","year":"2009","journal-title":"Pain"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0306-4522(93)90551-P","article-title":"Mechanical hyperalgesia in streptozotocin-diabetic rats","volume":"52","author":"Ahlgren","year":"1993","journal-title":"Neuroscience"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3959(93)90059-X","article-title":"Streptozocin-induced diabetic rats: Behavioural evidence for a model of chronic pain","volume":"53","author":"Courteix","year":"1993","journal-title":"Pain"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(95)00402-7","article-title":"Different effects of two aldose reductase inhibitors on nociception and prostaglandin E","volume":"285","author":"Calcutt","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(96)03201-0","article-title":"Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: Effects of insulin, aldose reductase inhibition and lidocaine","volume":"68","author":"Calcutt","year":"1996","journal-title":"Pain"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(98)00037-2","article-title":"A pharmacologic analysis of mechanical hyperalgesia in streptozotocin\/diabetic rats","volume":"76","author":"Malcangio","year":"1998","journal-title":"Pain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","article-title":"Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat","volume":"80","author":"Field","year":"1999","journal-title":"Pain"},{"key":"ref_52","first-page":"1","article-title":"Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits","volume":"261","author":"Cameron","year":"1991","journal-title":"Am. J. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01220630","article-title":"Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibres","volume":"12","author":"Jakobsen","year":"1976","journal-title":"Diabetologia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0306-4522(00)00454-1","article-title":"Hyper-responsivity in a subset of C-fiber nociceptors in a model of painful diabetic neuropathy in the rat","volume":"102","author":"Chen","year":"2001","journal-title":"Neuroscience"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0306-4522(03)00486-X","article-title":"Altered temporal pattern of mechanically evoked C-fiber activity in a model of diabetic neuropathy in the rat","volume":"121","author":"Chen","year":"2003","journal-title":"Neuroscience"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.1523\/JNEUROSCI.2659-06.2006","article-title":"Abnormal function of C-fibers in patients with diabetic neuropathy","volume":"26","author":"Orstavik","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/jpet.108.139410","article-title":"Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy","volume":"326","author":"Bordet","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbabio.2008.03.009","article-title":"Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore","volume":"1777","author":"Leung","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10495-007-0723-y","article-title":"The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis","volume":"12","author":"Rasola","year":"2007","journal-title":"Apoptosis"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.freeradbiomed.2008.08.008","article-title":"Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage","volume":"45","author":"Cardoso","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI118909","article-title":"The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice","volume":"98","author":"Yen","year":"1996","journal-title":"J. Clin. Invest"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol. Toxicol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejheart.2007.11.002","article-title":"The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1\/2","volume":"10","author":"Berdeaux","year":"2008","journal-title":"Eur. J. Heart Fail"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1074\/jbc.M010603200","article-title":"Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling","volume":"276","author":"Scorrano","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1074\/jbc.M010604200","article-title":"The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ","volume":"276","author":"Petronilli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_67","unstructured":"Shahar, A.D., De Vellis, J., Vernadakis, A., and Haber, B. (1989). Dissection and Tissue Culture Manual of the Nervous System, A.R. Liss."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10989","DOI":"10.1073\/pnas.90.23.10989","article-title":"Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP","volume":"90","author":"Galli","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.04.034","article-title":"The adult rat hippocampal slice revisited with multi-electrode arrays","volume":"1096","author":"Steidl","year":"2006","journal-title":"Brain Res."},{"key":"ref_70","first-page":"484","article-title":"An in situ brain perfusion technique to study cerebrovascular transport in the rat","volume":"247","author":"Takasato","year":"1984","journal-title":"Am. J. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1471-4914(03)00046-7","article-title":"Mitochondria in cell death: Novel targets for neuroprotection and cardioprotection","volume":"9","author":"Mattson","year":"2003","journal-title":"Trends Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1208\/aapsj080362","article-title":"Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents","volume":"8","author":"Szeto","year":"2006","journal-title":"Aaps. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/ph2030150","article-title":"Mitochondrial medicine and the neurodegenerative mitochondriopathies","volume":"2","author":"Swerdlow","year":"2009","journal-title":"Pharmaceuticals"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","article-title":"Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1","volume":"18","author":"Kong","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/jnr.22106","article-title":"Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy","volume":"87","author":"Acsadi","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.16.5.475","article-title":"Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis","volume":"16","author":"Afifi","year":"1966","journal-title":"Neurology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00691318","article-title":"The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis","volume":"55","author":"Atsumi","year":"1981","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00005072-198409000-00002","article-title":"Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis","volume":"43","author":"Hirano","year":"1984","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(96)12314-4","article-title":"Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis","volume":"204","author":"Sasaki","year":"1996","journal-title":"Neurosci. Lett"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2005.07.020","article-title":"Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: A temporal study in man","volume":"198","author":"Zoll","year":"2006","journal-title":"Exp. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1113\/jphysiol.2003.041905","article-title":"Stimulation-induced mitochondrial [Ca2+] elevations in mouse motor terminals: Comparison of wild-type with SOD1-G93A","volume":"549","author":"Vila","year":"2003","journal-title":"J. Physiol."},{"key":"ref_84","unstructured":"David, G., and Barrett, E.F. (,  2003). Quantal release from motor nerve terminals of mice expressing the G93A mutation of human superoxide dismutase 1 (SOD1G93A). Neuroscience Meeting, New Orleans, LA, USA."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lewinski, F.V., and Keller, B.U. (2005). Ca(2+), mitochondria and selective motoneuron vulnerability: Implications for ALS. Trends Neurosci., 494\u2013500.","DOI":"10.1016\/j.tins.2005.07.001"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"29626","DOI":"10.1074\/jbc.M203065200","article-title":"Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice","volume":"277","author":"Mattiazzi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"Pasinelli","year":"2004","journal-title":"Neuron"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1471-4159.2003.02181.x","article-title":"An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment","volume":"88","author":"Kirkinezos","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2009.02.015","article-title":"The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice","volume":"218","author":"Martin","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref_91","unstructured":"Abitbol, J.L., Cuvier, V., Bordet, T., Drouot, C., Berna, P., and Pruss, R.M. (December, January 30). Safety and pharmacokinetics of repeated doses of TRO19622, a drug candidate for the treatment of amyotrophic lateral sclerosis and spinal muscular atrophy. ALS\/MND International Symposium, Yokohama, Japan."},{"key":"ref_92","unstructured":"Estournet, B., Chabrol, B., Cuisset, J.M., Cances, C., Strub-Wourgaft, N., Cuvier, V., Bassissi, F., Bordet, T., Pruss, R., and Abitbol, J.L. (May, January 25). Safety and pharmacokinetics (PK) of TRO19622 in Spinal Muscular Atrophy (SMA) children and adults. 61st Annual Meeting American Academy of Neurology, Seattle, WA, USA."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/2\/345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:01:21Z","timestamp":1760220081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/2\/345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":92,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,2]]}},"alternative-id":["ph3020345"],"URL":"https:\/\/doi.org\/10.3390\/ph3020345","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,28]]}}}